Core Viewpoint - The Hong Kong stock market is experiencing a new wave of share buybacks, with significant participation from leading technology companies, particularly in the healthcare sector [1][2]. Group 1: Share Buyback Activity - In November, companies listed on the Hong Kong stock market repurchased over 700 million shares, with over 300 million shares repurchased in just the first few trading days of December [1]. - Medical technology company Yidu Tech (02158) has been a prominent player in this buyback trend, repurchasing 155,000 shares at HKD 5.1 per share on December 12, totaling approximately HKD 790,000 [1]. - Yidu Tech has conducted seven buybacks in December, accumulating around 2.11 million shares repurchased, with a total expenditure exceeding HKD 10.8 million [1]. Group 2: Company Performance and Developments - Yidu Tech's buyback activity reflects the company's strong recognition of its own value, supported by improved performance and business expansion [1]. - For the fiscal year 2026, Yidu Tech reported a significant improvement in profitability and operational efficiency, with adjusted EBITDA reaching approximately HKD 54 million, doubling compared to the same period last year [1]. - The company is making strides in AI healthcare innovation, participating in national AI application pilot projects in Beijing and winning bids for clinical research projects, as well as expanding its "Hui Min Bao" business in Hebei and Guangzhou [1].
医渡科技(02158)12月已回购超1080万港元 收盘涨超3%